Adjust Font Increase Font Decrease Font
  • Email
  • Print
  • RSS Feed

Media Releases

Statement to Physician Payments Sunshine Act Final Rule
WASHINGTON, D.C. (February 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “PhRMA is currently reviewing the final regulation of the Physician Payments Sunshine Act and looks forward to seeing how CMS addressed key concerns that were previously raised. PhRMA remains committed to the principles of the Sunshine Act and continues to believe that careful implementation is essential to ensuring that Sunshine fulfills its objective of usable, transparent, and understandable sharing of information.” About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies...
Read more

Latest Releases

PhRMA Announces Two New Research Associate Members
9/14/2012
Ipsen Biopharmaceuticals and Onyx Pharmaceuticals Join PhRMA as Research Associate Members
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that two companies – Ipsen Biopharmaceuticals and Onyx Pharmaceuticals – have joined the association as new research associate members. PhRMA’s Board of Directors recently approved the membership expansion.
More
From Setbacks to Stepping Stones: Alzheimer’s disease
9/12/2012
As knowledge of Alzheimer’s increases, hope remains high for millions of affected patients and caregivers with nearly 100 medicines in the pipeline
The Pharmaceutical Research and Manufacturers of America (PhRMA) released two new reports at its first annual Research and Hope Awards ceremony, which celebrated advancements made in research and patient care for Alzheimer’s disease. The reports detail how obstacles play a role in moving Alzheimer’s research forward, as well as the progress that is being made to help confront this complicated disease.
More
Researchers and Patient Advocates Honored with PhRMA Award
9/7/2012
Recipients recognized for outstanding contributions to the fight against Alzheimer’s disease
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year’s award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care for Alzheimer’s disease.
More
PhRMA to Bestow New Research and Hope Award
8/27/2012
More
PhRMA Statement on Flawed British Medical Journal Analysis
8/9/2012
PhRMA SVP Matthew Bennett issued a statement today on a recent analysis in the British Medical Journal.
More
PhRMA Statement on Medicare Part D Premiums
8/7/2012
“Since its inception, Medicare Part D has provided good access to medicines at an affordable cost. This exemplary track record of success continues with today’s announcement by the Department of Health and Human Services that beneficiaries’ average monthly Part D premiums for 2013 will remain steady for the third consecutive year at $30 – 50 percent less than original premium projections.
More

Subscribe to our Email Updates